Larvol Delta - Assessment-of-the-Initial-Efficacy-and-Safety-of-BRM424-Ophthalmic-Solutions-in-Patients-With-Neurotrophic-Keratitis

BRM424 - BRIM Biotech

http://clinicaltrials.gov/ct2/show/NCT05927428

Oct 28, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next